Validation of rapid suicidality screening in epilepsy using the NDDIE

Mula M, McGonigal A, Micoulaud-Franchi J-A, May TW, Labudda K, Brandt C (2016)
EPILEPSIA 57(6): 949-955.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ;
Abstract / Bemerkung
Objective: Standard mortality ratio for suicide in patients with epilepsy is three times higher than in the general population, and such a risk remains high even after adjusting for clinical and socioeconomic factors. It is thus important to have suitable screening instruments and to implement care pathways for suicide prevention in every epilepsy center. The aim of this study is to validate the use of the Neurological Disorder Depression Inventory for Epilepsy (NDDIE) as a suicidality-screening instrument. Methods: The study sample included adult patients with epilepsy assessed with the Mini International Neuropsychiatric Interview (MINI) and the NDDIE. A high suicidality risk according to the Suicidality Module of the MINI was considered the gold standard. Receiver operating characteristic analyses for NDDIE total and individual item scores were computed and subsequently compared using a nonparametric approach. The best possible cutoff was identified with the highest Youden index (J). Likelihood ratios were then computed, and specificity, sensitivity, positive, and negative predictive values calculated. Results: The study sample consisted of 380 adult patients with epilepsy: 46.3% male; mean age was 39.4 +/- 14.6; 76.7% had a diagnosis of focal epilepsy; mean age at onset of the epilepsy was 23.3 +/- 17.5. According to the MINI, 74 patients (19.5%) fulfilled criteria for a major depressive episode and 19 (5%) presented a high suicidality risk. A score >2 (J = 0.751) for item 4 "I'd be better off dead" of the NDDIE displayed excellent psychometric properties with a good to excellent validity (area under the curve [AUC] 0.906; 95% confidence interval [CI] 0.820-0.992; p < 0.001), sensitivity 84.21% (95% CI 60.4-96.6), specificity 90.86% (95% CI 87.4-93.6), likelihood ratio+ 9.21 (95% CI 6.3-13.5), likelihood ratio-0.17 (95% CI 0.06-0.50). Significance: Item 4 of the NDDIE has shown to be an excellent suicidality screening instrument allowing the development of further care pathways for suicide prevention in epilepsy centers.
Erscheinungsjahr
Zeitschriftentitel
EPILEPSIA
Band
57
Zeitschriftennummer
6
Seite
949-955
ISSN
eISSN
PUB-ID

Zitieren

Mula M, McGonigal A, Micoulaud-Franchi J-A, May TW, Labudda K, Brandt C. Validation of rapid suicidality screening in epilepsy using the NDDIE. EPILEPSIA. 2016;57(6):949-955.
Mula, M., McGonigal, A., Micoulaud-Franchi, J. - A., May, T. W., Labudda, K., & Brandt, C. (2016). Validation of rapid suicidality screening in epilepsy using the NDDIE. EPILEPSIA, 57(6), 949-955. doi:10.1111/epi.13373
Mula, M., McGonigal, A., Micoulaud-Franchi, J. - A., May, T. W., Labudda, K., and Brandt, C. (2016). Validation of rapid suicidality screening in epilepsy using the NDDIE. EPILEPSIA 57, 949-955.
Mula, M., et al., 2016. Validation of rapid suicidality screening in epilepsy using the NDDIE. EPILEPSIA, 57(6), p 949-955.
M. Mula, et al., “Validation of rapid suicidality screening in epilepsy using the NDDIE”, EPILEPSIA, vol. 57, 2016, pp. 949-955.
Mula, M., McGonigal, A., Micoulaud-Franchi, J.-A., May, T.W., Labudda, K., Brandt, C.: Validation of rapid suicidality screening in epilepsy using the NDDIE. EPILEPSIA. 57, 949-955 (2016).
Mula, Marco, McGonigal, Aileen, Micoulaud-Franchi, Jean-Arthur, May, Theodor W., Labudda, Kirsten, and Brandt, Christian. “Validation of rapid suicidality screening in epilepsy using the NDDIE”. EPILEPSIA 57.6 (2016): 949-955.

5 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Successful health communication in epileptology.
Schachter SC., Seizure 44(), 2017
PMID: 27780659
Depression in epilepsy.
Mula M., Curr Opin Neurol 30(2), 2017
PMID: 28157720
Psychiatric comorbidities in epilepsy.
Josephson CB, Jetté N., Int Rev Psychiatry 29(5), 2017
PMID: 28681667

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 27012840
PubMed | Europe PMC

Suchen in

Google Scholar